a month ago
NTRA
AnalystsDavid WestenbergDavid Westenberg's Stock Forecasts
AnalystsDavid Westenberg
Analyst Ranking
Top 5%
#230 out of 5153 analysts
Average Return
+21.7%
Win Rate
60%73 out of 122
Risk vs Reward
Poor
Good
David Westenberg's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +204.75% | $42.33 | $129.00 | 2023-10-15 - 2024-10-15 | Strong Buy |
Exact Sciences CorpEXAS | +148.69% | $40.91 | $101.74 | 2025-08-10 - 2025-12-15 | Strong Buy |
Guardant Health IncGH | +144.86% | $41.93 | $102.67 | 2025-05-05 - 2025-12-15 | Strong Buy |
Guardant Health IncGH | +137.72% | $43.19 | $102.67 | 2025-02-25 - 2025-12-15 | Strong Buy |
Natera IncNTRA | +133.26% | $47.08 | $109.82 | 2023-05-29 - 2024-05-29 | Strong Buy |
David Westenberg Analyst Color
Get additional color on David Westenberg's coverage of popular stocks
a month ago
EXAS
2 months ago
GH
2 months ago
ADPT
3 months ago
WGS
4 months ago
NTRA
4 months ago
ADPT
4 months ago
WGS
7 months ago
GH
9 months ago
TEM
9 months ago
NTRA
a year ago
ADPT
a year ago
EXAS
a year ago
GH
a year ago
NTRA
2 years ago
NTRA
2 years ago
ZTS
3 years ago
NVTAQ
3 years ago
CTKB
David Westenberg's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Billiontoone IncBLLN | 1 | Strong Buy | $150.00 | +55.22% | Initiates Coverage On | 15 days ago |
10x Genomics IncTXG | 3 | Hold | $19.00 | +20.56% | Maintains | a month ago |
Tempus Ai IncTEM | 6 | Hold | $80.00 | +16.50% | Maintains | a month ago |
Pacific Biosciences Of California IncPACB | 10 | Hold | $2.00 | -5.66% | Maintains | a month ago |
Natera IncNTRA | 17 | Strong Buy | $230.00 | +0.70% | Maintains | a month ago |
Fulgent Genetics IncFLGT | 10 | Hold | $30.00 | +11.44% | Maintains | a month ago |
Exact Sciences CorpEXAS | 13 | Strong Buy | $80.00 | -21.37% | Maintains | a month ago |
Cytek Biosciences IncCTKB | 10 | Strong Buy | $7.50 | +61.64% | Maintains | a month ago |
Quest Diagnostics IncDGX | 8 | Hold | $200.00 | +8.63% | Maintains | 2 months ago |
Guardant Health IncGH | 10 | Strong Buy | $90.00 | -12.34% | Maintains | 2 months ago |
Neogen CorpNEOG | 13 | Hold | $6.50 | -5.11% | Reiterates | 2 months ago |
Adaptive Biotechnologies CorpADPT | 12 | Strong Buy | $20.00 | +27.47% | Maintains | 2 months ago |
Genedx Holdings CorpWGS | 3 | Strong Buy | $140.00 | -7.04% | Maintains | 3 months ago |
Zoetis IncZTS | 12 | Strong Buy | $215.00 | +77.72% | Maintains | 4 months ago |
Idexx Laboratories IncIDXX | 8 | Hold | $700.00 | -0.08% | Maintains | 4 months ago |
Elanco Animal Health IncELAN | 10 | Hold | $18.00 | -17.05% | Maintains | 4 months ago |
Neogenomics IncNEO | 10 | Strong Buy | $11.00 | -7.72% | Maintains | 4 months ago |
Illumina IncILMN | 15 | Strong Buy | $185.00 | +37.12% | Maintains | 7 months ago |
Labcorp Holdings IncLH | 4 | Hold | $280.00 | +6.33% | Maintains | 7 months ago |
Akoya Biosciences IncAKYA | 8 | Hold | $1.65 | +27.91% | Maintains | 8 months ago |
Insight Molecular Diagnostics IncIMDX | 7 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Invitae CorpNVTAQ | 5 | Strong Sell | $0.30 | N/A | Maintains | 2 years ago |
Heska CorpHSKA | 6 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Covetrus IncCVET | 1 | Strong Buy | $30.00 | N/A | Upgrades | 4 years ago |
Petiq IncPETQ | 1 | Strong Buy | $44.00 | N/A | Maintains | 5 years ago |
Quidelortho CorpQDEL | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Trupanion IncTRUP | 1 | Hold | N/A | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.